Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

CTL Analysis for Tumor Vaccines.

Rosato A, Milan G, Zambon A, Zanovello P, Collavo D.

Methods Mol Med. 2000;29:123-32. doi: 10.1385/1-59259-688-6:123.

PMID:
21374315
2.

DNA-based vaccination against tumors expressing the P1A antigen.

Rosato A, Milan G, Collavo D, Zanovello P.

Methods. 1999 Sep;19(1):187-90.

PMID:
10525455
3.

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.

Quintieri L, Rosato A, Amboldi N, Vizler C, Ballinari D, Zanovello P, Collavo D.

Br J Cancer. 1999 Mar;79(7-8):1067-73.

4.

DNA immunization in mice against virus-induced tumor antigens.

Milan G, Rosato A, Zambon A, Zanovello P, Collavo D.

Adv Exp Med Biol. 1998;451:311-4. No abstract available.

PMID:
10026889
5.

Dissecting the immune response to moloney murine sarcoma/leukemia virus-induced tumors by means of a DNA vaccination approach.

Milan G, Zambon A, Cavinato M, Zanovello P, Rosato A, Collavo D.

J Virol. 1999 Mar;73(3):2280-7.

6.

Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity.

Vizler C, Rosato A, Calderazzo F, Quintieri L, Fruscella P, Wainstok de Calmanovici R, Mantovani A, Vecchi A, Zanovello P, Collavo D.

Br J Cancer. 1998 Feb;77(4):656-62.

7.

CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P815A.

Rosato A, Zambon A, Milan G, Ciminale V, D'Agostino DM, Macino B, Zanovello P, Collavo D.

Hum Gene Ther. 1997 Aug 10;8(12):1451-8.

PMID:
9287145
8.

CD45 regulates apoptosis induced by extracellular adenosine triphosphate and cytotoxic T lymphocytes.

Macino B, Zambon A, Milan G, Cabrelle A, Ruzzene M, Rosato A, Mandruzzato S, Quintieri L, Zanovello P, Collavo D.

Biochem Biophys Res Commun. 1996 Sep 24;226(3):769-76.

PMID:
8831688
9.

Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells.

Monastra G, Cabrelle A, Zambon A, Rosato A, Macino B, Collavo D, Zanovello P.

Cell Immunol. 1996 Jul 10;171(1):102-10.

PMID:
8660844
10.

Anti-L-selectin monoclonal antibody treatment in mice enhances tumor growth by preventing CTL sensitization in peripheral lymph nodes draining the tumor area.

Rosato A, Zambon A, Macino B, Mandruzzato S, Bronte V, Milan G, Zanovello P, Collavo D.

Int J Cancer. 1996 Mar 15;65(6):847-51.

11.

Protein tyrosine kinases and phosphatases control apoptosis induced by extracellular adenosine 5'-triphosphate.

Bronte V, Macino B, Zambon A, Rosato A, Mandruzzato S, Zanovello P, Collavo D.

Biochem Biophys Res Commun. 1996 Jan 5;218(1):344-51.

PMID:
8573158
12.

Role of anti-LFA-1 and anti-ICAM-1 combined MAb treatment in the rejection of tumors induced by Moloney murine sarcoma virus (M-MSV).

Rosato A, Mandruzzato S, Bronte V, Zambon A, Macino B, Calderazzo F, Zanovello P, Collavo D.

Int J Cancer. 1995 May 4;61(3):355-62.

PMID:
7729948
13.

Inhibition of protein tyrosine phosphorylation prevents T-cell-mediated cytotoxicity.

Rosato A, Zambon A, Mandruzzato S, Bronte V, Macino B, Calderazzo F, Collavo D, Zanovello P.

Cell Immunol. 1994 Dec;159(2):294-305.

PMID:
7994761
14.

Role of extracellular ATP in cell-mediated cytotoxicity: a study with ATP-sensitive and ATP-resistant macrophages.

Zambon A, Bronte V, Di Virgilio F, Hanau S, Steinberg TH, Collavo D, Zanovello P.

Cell Immunol. 1994 Jul;156(2):458-67.

PMID:
8025958
15.

Adoptive transfer of lymphokine-activated killer cells loaded with 4'-deoxy-4'-iododoxorubicin: therapeutic effect in mice bearing lung metastases.

Mandruzzato S, Rosato A, Bronte V, Zanovello P, Amboldi N, Ballinari D, Collavo D.

Cancer Res. 1994 Feb 15;54(4):1016-20.

PMID:
8313356
16.

Synergistic effect of extracellular adenosine 5'-triphosphate and tumor necrosis factor on DNA degradation.

Bronte V, Zanovello P, Rosato A, Zambon A, Mandruzzato S, Pizzo P, Di Virgilio F, Collavo D.

Cell Immunol. 1993 Nov;152(1):110-9.

PMID:
8242754
17.

Inhibition of CTL-line lysis after gangliosides treatment.

Pollis F, Bronte V, Mandruzzato S, Rosato A, Zambon A, Zanovello P, Zambello R, Callegaro L, Collavo D.

Pharmacol Res. 1992 Sep;26 Suppl 2:190-1. No abstract available.

PMID:
1409305
18.

Therapeutical effect of 4'-deoxy-4'-iododoxorubicin-loaded LAK cells in mice bearing lung metastases.

Mandruzzato S, Rosato A, Bronte V, Pollis F, Zambon A, Zanovello P, Collavo D.

Pharmacol Res. 1992 Sep;26 Suppl 2:124-5. No abstract available.

PMID:
1409274
19.

Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.

Zanovello P, Rosato A, Bronte V, Mandruzzato S, Cerundolo V, Collavo D.

Cancer Immunol Immunother. 1992;35(1):27-32.

PMID:
1611620
20.

The in vivo role of leukocyte function-associated antigen-1 in cytotoxic cell activity against tumors induced by Moloney-murine sarcoma/leukemia retroviral complex.

Rosato A, Bronte V, Pollis F, Mandruzzato S, Zambon A, Zanovello P, Collavo D.

Leukemia. 1992;6 Suppl 3:166S-167S.

PMID:
1602816
21.

Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.

Rosato A, Bronte V, Mandruzzato S, Zambon A, Calderazzo F, Biasi G, Zanovello P, Collavo D.

Int J Cancer Suppl. 1992;7:24-7.

PMID:
1385341
22.

Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice.

Biasi G, Facchinetti A, Panozzo M, Zanovello P, Chieco-Bianchi L, Collavo D.

J Immunol. 1991 Oct 1;147(7):2284-9.

PMID:
1833453
23.

An improved method for the detection of DNA fragmentation.

Facchinetti A, Tessarollo L, Mazzocchi M, Kingston R, Collavo D, Biasi G.

J Immunol Methods. 1991 Jan 24;136(1):125-31.

PMID:
1704901
24.

Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins.

Zanovello P, Rosato A, Bronte V, Cerundolo V, Collavo D.

Ann Ist Super Sanita. 1991;27(1):91-5. Review.

PMID:
1958033
25.

Induction of Moloney murine sarcoma virus tolerance in adult mice by anti-CD4 monoclonal antibody treatment.

Biasi G, Mazzocchi M, Facchinetti A, Panozzo M, Zanovello P, Collavo D, Chieco-Bianchi L.

Cancer Res. 1990 Sep 1;50(17 Suppl):5703S-5706S.

26.

Extracellular ATP as a possible mediator of cell-mediated cytotoxicity.

Di Virgilio F, Pizzo P, Zanovello P, Bronte V, Collavo D.

Immunol Today. 1990 Aug;11(8):274-7. Review.

PMID:
2206271
27.

In vitro induction of immunological tolerance.

Biasi G, Mazzocchi M, Zanovello P, Collavo D, Festenstein H.

Cell Immunol. 1989 Dec;124(2):187-201.

PMID:
2531040
28.
29.

Resistance of lymphokine-activated T lymphocytes to cell-mediated cytotoxicity.

Zanovello P, Cerundolo V, Bronte V, Giunta M, Panozzo M, Biasi G, Collavo D.

Cell Immunol. 1989 Sep;122(2):450-60.

PMID:
2788517
30.

Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosis.

Zanovello P, Rosato A, Bronte V, Cerundolo V, Treves S, Di Virgilio F, Pozzan T, Biasi G, Collavo D.

J Exp Med. 1989 Sep 1;170(3):665-77.

31.

Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation.

Zanovello P, Vallerani E, Biasi G, Landolfo S, Collavo D.

J Immunol. 1988 Feb 15;140(4):1341-4.

PMID:
2830339
32.

HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virus.

Amadori A, Faulkner-Valle GP, De Rossi A, Zanovello P, Collavo D, Chieco-Bianchi L.

Clin Immunol Immunopathol. 1988 Jan;46(1):37-54.

PMID:
3257177
33.

Immunologic unresponsiveness to murine leukemia virus antigens: mechanisms and role in tumor development.

Chieco-Bianchi L, Collavo D, Biasi G.

Adv Cancer Res. 1988;51:277-306. Review. No abstract available.

PMID:
2851924
34.

Lymphokine-induced cytotoxic cell generation in thymus and spleen cell cultures.

Biasi G, Rivarollo R, Colmagro R, Ronchese F, Collavo D.

J Biol Regul Homeost Agents. 1987 Jul-Sep;1(3):119-25.

PMID:
3509738
35.

Calcium and inositolphosphates in the activation of T cell-mediated cytotoxicity.

Treves S, Di Virgilio F, Cerundolo V, Zanovello P, Collavo D, Pozzan T.

J Exp Med. 1987 Jul 1;166(1):33-42.

36.

Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.

Cerundolo V, Zanovello P, McIntosh D, Fabbris R, Davies AJ, Collavo D.

Br J Cancer. 1987 Apr;55(4):413-9.

38.

Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.

Ronchese F, Collavo D, Zanovello P, Cerundolo V, Biasi G.

Immunology. 1985 Feb;54(2):265-74.

39.

Role of infectious virus expression and immune response in retrovirus-induced oncogenesis.

Zanovello P, D'Andrea E, Ronchese F, De Rossi A, Collavo D, Chieco-Bianchi L.

Tumori. 1984 Feb 29;70(1):1-8.

PMID:
6324431
40.

Tolerance to viral antigens in Mov-13 mice carrying endogenized Moloney-murine leukemia virus.

Ronchese F, D'Andrea E, Collavo D, De Rossi A, Zanovello P, Chieco-Bianchi L.

Cell Immunol. 1984 Feb;83(2):379-88.

PMID:
6607132
41.

Reduction in precursors of cytotoxic T lymphocytes and of cells with natural killer-like activity in spleens of cyclophosphamide-treated mice.

Collavo D, Ronchese F, Zanovello P, Cerundolo V, Biasi G.

Int J Immunopharmacol. 1984;6(5):529-34.

PMID:
6334044
42.

Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).

Zanovello P, Collavo D, Ronchese F, De Rossi A, Biasi G, Chieco-Bianchi L.

Immunology. 1984 Jan;51(1):9-16.

43.

Persistence and specificity of accessory cell impairment in M-MuLV neonatally injected mice.

Biasi G, Saggin L, Dazzi F, Collavo D.

Transplant Proc. 1983 Dec;15(4):2125-7. No abstract available.

PMID:
6608813
44.

Selective failure of accessory cell function in Moloney murine leukemia virus-tolerant mice.

Biasi G, Collavo D, Chieco-Bianchi L.

J Immunol. 1983 Jul;131(1):16-8.

PMID:
6223070
45.

Protection from spontaneous lymphoma development in SJL/J(v+) mice neonatally injected with dualtropic SJL-151 virus.

De Rossi A, D'Andrea E, Biasi G, Collavo D, Chieco-Bianchi L.

Proc Natl Acad Sci U S A. 1983 May;80(9):2775-9.

46.

Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.

Biasi G, Saggin L, Dazzi F, De Rossi A, Collavo D.

J Immunol. 1983 Mar;130(3):1447-50.

PMID:
6185589
47.

Natural history of M-MSV tumors in mice carrying endogenized Moloney leukemia virus.

Chieco-Bianchi L, D'Andrea E, De Rossi A, Zanovello P, Ronchese F, Collavo D.

Haematol Blood Transfus. 1983;28:275-9. No abstract available.

PMID:
6602736
49.

Leukemia-cell rejection due to T-region encoded antigens.

Biasi G, Collavo D, Zanovello P, Chieco-Bianchi L.

Immunogenetics. 1981 Mar 1;12(5-6):433-43.

PMID:
6971250
50.

Supplemental Content

Loading ...
Support Center